Arjuna Therapeutics — Seed · €571K

Pre-Series A bridge round run as an equity crowdfunding campaign on Capital Cell. It launched on 18 Sep 2024 and closed on 9 Jan 2025 with €571,450 from 179 investors, 114% of its €500K target, for 4.6% equity at a €10.3M pre-money valuation. The money is for finding the best Ag5 dose in animal models before a Series A that would fund first human trials. The date is the campaign close shown on Capital Cell; no press release was found.